Past Webinar

Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation

Healthcare7/25/2024 3:00 PM

Description

Nucleic acid-based therapies have become the third major drug class after small molecules and antibodies. The role of nucleic acid-based therapies has been strengthened by recent regulatory approvals and tremendous clinical success. In this review, we look at the major obstacles that have hindered the field, the historical milestones that have been achieved, and what is yet to be resolved and anticipated soon. This webinar provides a view of the key innovations that are expanding nucleic acid capabilities, setting the stage for the future of nucleic acid therapeutics.

Speakers: Hassan Fakih, PhD (UMass Chan Medical School) and Jillian Belgrad, MD, PhD Candidate (UMass Chan Medical School)

Comments

Rate This Webinar

community rating (0 votes):

Rate or Review This Webinar

Publisher

Oligonucleotide Therapeutics Society

The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster research and development of oligonucleotide therapeutics. The Founders’ vision was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. Oligonucleotide therapeutics are now being used to successfully treat diseases and have the potential for widespread application. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics. The OTS offers scholarships, awards, and travel grants annually.